Glen Manglapus

Title: Glen Manglapus: Innovator in Radiation Injury Assessment

Introduction

Glen Manglapus is a notable inventor based in Bel Air, MD (US). He has made significant contributions to the field of medical diagnostics, particularly in assessing radiation injury and exposure. His innovative work has the potential to enhance treatment protocols for individuals affected by radiation.

Latest Patents

Glen Manglapus holds a patent for "Biomarker panels for assessing radiation injury and exposure." This patent involves methods and kits designed to evaluate radiation injury and exposure in subjects. The methods include measuring levels of at least two protein biomarkers from different biological pathways and correlating these levels with assessments of radiation injury. Additionally, the patent incorporates the use of peripheral blood cell counts and serum enzyme biomarkers, evaluated shortly after suspected radiation exposure. This comprehensive approach provides clinicians with valuable tools for accurately assessing the extent of radiation injury, thereby aiding in the determination of appropriate treatment protocols.

Career Highlights

Glen Manglapus is associated with the Henry M. Jackson Foundation for the Advancement of Military Medicine Inc. His work at this institution underscores his commitment to advancing medical science and improving patient outcomes in the context of military medicine.

Collaborations

Glen has collaborated with esteemed colleagues such as William F. Blakely and Natalia I. Ossetrova. These partnerships reflect a collaborative spirit in the pursuit of innovative solutions to complex medical challenges.

Conclusion

Glen Manglapus is a pioneering inventor whose work in radiation injury assessment is making a significant impact in the medical field. His contributions are vital for improving the accuracy of radiation exposure assessments and enhancing treatment strategies for affected individuals.